[Myopathy due to statins, a dose-dependent effect, and of what kind?].
León Vázquez
F
F
Médico de Familia, CS San Juan de la Cruz, Pozuelo de Alarcón, Madrid, Spain.
Llanes De Torres
R
R
Morón Merchante
I
I
D000328:Adult; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000069059:Atorvastatin; D004796:Clinical Enzyme Tests; D003402:Creatine Kinase / Q000097:blood; D006538:Heptanoic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008148:Lovastatin / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D009135:Muscular Diseases / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects*; D011758:Pyrroles / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011725:Pyridines; D011758:Pyrroles; D008148:Lovastatin; D000069059:Atorvastatin; C086276:cerivastatin; D003402:Creatine Kinase